Boehringer Ingelheim
Dr. Dalia Mahmoud Amr is a distinguished medical professional with extensive experience in clinical development and medical affairs, currently serving as Senior Director at Boehringer Ingelheim since June 2011, specializing in immunology and respiratory portfolios. Prior roles at Boehringer Ingelheim include Director positions overseeing clinical development in various therapeutic areas such as interstitial lung disease and serving as Therapy Area Lead for the Middle East, Turkey, and Africa. Additionally, Dr. Amr has been a Chest Diseases Specialist and Clinical Toxicologist at the National Egyptian Center for Clinical Toxicology and Research since June 2004. Education includes a Bachelor of Medicine and General Surgery from Cairo University, a Master of Science in Chest Diseases and Tuberculosis, a diploma in Healthcare and Hospital Management from The American University in Cairo, and an Accelerate program at Harvard Medical School.
This person is not in any offices
Boehringer Ingelheim
116 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.